**Core Concept**
The patient's presentation suggests hyperkalemia, a life-threatening electrolyte imbalance characterized by elevated serum potassium levels. This condition can lead to cardiac arrhythmias and muscle weakness due to potassium's crucial role in cardiac and neuromuscular function.

**Why the Correct Answer is Right**
The management of hyperkalemia involves stabilizing cardiac membranes, shifting potassium into cells, and removing excess potassium from the body. Potassium-binding resins like polystyrene sulfonate (Option C) are used to exchange potassium ions for sodium or calcium ions in the gastrointestinal tract, promoting its excretion. In contrast, insulin and glucose (Option A) help lower potassium levels by driving potassium into cells. Calcium gluconate (Option B) is used to stabilize cardiac membranes by antagonizing the effects of excess potassium on cardiac cells. Therefore, the correct answer is the option that does not fit into this management strategy.

**Why Each Wrong Option is Incorrect**
**Option A:** Insulin and glucose are used in the management of hyperkalemia to drive potassium into cells, making this option incorrect.
**Option B:** Calcium gluconate is used to stabilize cardiac membranes in cases of hyperkalemia, making this option incorrect.

**Clinical Pearl / High-Yield Fact**
When managing hyperkalemia, it's essential to remember that insulin and glucose can lower potassium levels quickly, but this effect is temporary and requires repeated administration. Therefore, potassium-binding resins and other treatments should be used in conjunction with insulin and glucose to achieve a more sustained reduction in potassium levels.

**Correct Answer:** D